Ring, Band or Suture in Tricuspid Annuloplasty for Functional Tricuspid Regurgitation; Which is Better and More Durable?
Background: In this study, we evaluate different annuloplasty modalities to repair functional tricuspid regurgitation.
Patients and methods: Between January 2011 and
January 2017, 200 patients with moderate or greater functional tricuspid regurgitation received tricuspid valve repair as part of primary surgeries on the left side of their cardiac valves. Of these, 39 patients received rings (Group A), 84 patients received bands (Group B), and 77 patients received suture annuloplasty (Group C).
Results: Two patients from Group C were operated on again, during the primary hospital stay due to severe symptomatic tricuspid regurgitation. The degrees of early postoperative tricuspid regurgitation – mean vena contracta and mean jet area – significantly were higher in Group C. During a mean follow-up period of 26 ± 12.6 months, 5 patients within Group C (6.85%) and one patient in Group B (1.3%) were operated on again with tricuspid valve replacement due to severe symptomatic tricuspid incompetence. Also during follow up, mean degrees of tricuspid regurgitation, mean vena contracta, and mean jet areas significantly were higher in Group C.
Conclusion: Patients who received rings followed by band annuloplasty had better early and late results with lower recurrence rates than those who received suture annuloplasty
Bernal JM, Gutierrez-Morlote J, Llorca J, et al. 2004. Tricuspid valve repair: an old disease, a modern experience. Ann Thorac Surg 78: 2069–74.
Bianchi G, Solinas M, Bevilacqua S, Glauber M. 2009. Which patient undergoing mitral valve surgery should also have the tricuspid repair? Interact Cardiovasc Thorac Surg 9:1009–20.
Calafiore AM, Di Mauro M. 2011. Tricuspid Valve Repair—Indications and Techniques: Suture Annuloplasty and Band Annuloplasty. Operative Techniques in Thoracic and Cardiovascular Surgery 16:86-96.
Chan KM, Zakkar M, Amirak E, Punjabi PP. 2009. Tricuspid valve disease: pathophysiology and optimal management. Prog Cardiovasc Dis 51:482–6.
Dreyfus GD, Corbi PJ, Chan KM, Bahrami T. 2005. Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair? Ann Thorac Surg 79:127–32.
Gatti G, Maffei G, Lusa AM, Pugliese P. 2001. Tricuspid Valve Repair With the Cosgrove-Edwards Annuloplasty System: Early Clinical and Echocardiographic Results. Ann Thorac Surg 72:764 –7.
Guenther T, Mazzitelli D, Noebauer C, et al. 2013. Tricuspid valve repair: is ring annuloplasty superior? Eur J Cardiothorac Surg 43:58–65.
Matsunaga A, Duran CM. 2005. Progression of tricuspid regurgitation after repaired functional ischemic mitral regurgitation. Circulation 112:I453–7.
McCarthy PM, Bhudia SK, Rajeswaran J, et al. 2004. Tricuspid valve repair: Durability and risk factors for failure. J Thorac Cardiovasc Surg 127:674–85.
Morishita A, Kitamura M, Noji S, et al. 2002. Long-term results after De Vega’s tricuspid annuloplasty. J Cardiovasc Surg (Torino) 43:773–7.
Naqshband MS, Abid AR, Akhtar RP, Waheed A, Khan JS. 2010. Functional tricuspid regurgitation in rheumatic heart disease: surgical options. Ann Thorac Cardiovasc Surg 16: 417–25.
Nath J, Foster E, Heidenreich PA. 2004. Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol 43:405–9.
Navia JL, Brozzi NA, Klein AL, et al. 2012. Moderate tricuspid regurgitation with left-sided degenerative heart valve disease: to repair or not to repair? Ann Thorac Surg 93:59–69.
Navia JL, Nowicki ER, Blackstone EH, et al. 2010. Surgical management of secondary tricuspid valve regurgitation: annulus, commissure, or leaflet procedure? J Thorac Cardiovasc Surg 139:1473–82.
Parolari A, Barili F, Pilozzi A, Pacini D. 2014. Ring or Suture Annuloplasty for Tricuspid Regurgitation? A Meta-Analysis Review. Ann Thorac Surg 98:2255–63.
Rogers JH, Bolling SF. 2009. The tricuspid valve: Current perspective and evolving management of tricuspid regurgitation. Circ. 119:2718-25.15.
Tang GH, David TE, Singh SK, et al. 2006. Tricuspid valve repair with an annuloplasty ring results in improved long-term outcomes. Circulation 114:I577–81.
Van de Veire NR, Braun J, Delgado V, et al. 2011. Tricuspid annuloplasty prevents right ventricular dilatation and progression of tricuspid regurgitation in patients with tricuspid annular dilatation undergoing mitral valve repair. J Thorac Cardiovasc Surg 141:1431–9.
Wang G, Sun Z, Xia J, et al. 2008. Predictors of secondary tricuspid regurgitation after left-sided valve replacement. Surg Today 38:778–83.
Zhu TY, Wang JG, Meng X. 2013. Is a rigid tricuspid annuloplasty ring superior to a flexible band when correcting secondary tricuspid regurgitation? Interact Cardiovasc Thorac Surg 17:1009–14.
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).